Masahiro Kagabu

Researcher Name Resolver ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Cancers

International journal of molecular sciences

Medicina (Kaunas, Lithuania)

International journal of clinical oncology

University of Pennsylvania

Iwate Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Oct 01 2007 - Aug 31 2009

United States

visiting assistant professor :: Ovarian Cancer Research Center

Education History

Iwate Medical University Apr 01 1996 - Mar 31 2000

Japan

PHD :: graduate school of medicine

Publications

Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Masahiro Kagabu, Naoto Yoshino, Kazuyuki Murakami, Hideki Kawamura, Yutaka Sasaki, Yasushi Muraki, Tsukasa Baba
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. International journal of molecular sciences 24 (3) (2023)
Masahiro Kagabu, Naoto Yoshino, Kazuyuki Murakami, Hideki Kawamura, Yutaka Sasaki, Yasushi Muraki, Tsukasa Baba
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. International journal of molecular sciences 24 (3) (2023)
Masahiro Kagabu, Naoto Yoshino, Kazuyuki Murakami, Hideki Kawamura, Yutaka Sasaki, Yasushi Muraki, Tsukasa Baba
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. International journal of molecular sciences 24 (3) (2023)
Hidehiko Akashi, Nozomi Yachida, Haruka Ueda, Manako Yamaguchi, Kaoru Yamawaki, Ryo Tamura, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi, Yoshikazu Nagase, Yutaka Ueda, Masashi Ueda, Kaoru Abiko, Masahiro Kagabu, Tsukasa Baba, Hirofumi Nakaoka, Takayuki Enomoto, Junko Murai, Kosuke Yoshihara
SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma. Molecular cancer therapeutics (2023)
Tatsuyuki Chiyoda, Kosuke Yoshihara, Masahiro Kagabu, Satoru Nagase, Hidetaka Katabuchi, Mikio Mikami, Tsutomu Tabata, Yasuyuki Hirashima, Yoichi Kobayashi, Masanori Kaneuchi, Hideki Tokunaga, Tsukasa Baba
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis. International journal of clinical oncology 27 (8) (2022)
Tadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Tadahiro Shoji, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Hiroaki Itamochi
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers 13 (23) (2021)
Masahiro Kagabu, Takayuki Nagasawa, Shunsuke Tatsuki, Yasuko Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Tadahiro Shoji, Tsukasa Baba
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study. Medicina (Kaunas, Lithuania) 57 (6) (2021)
Masahiro Kagabu, Naoto Yoshino, Tatsunori Saito, Yuki Miura, Ryosuke Takeshita, Kazuyuki Murakami, Hideki Kawamura, Tsukasa Baba, Toru Sugiyama
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model. International journal of clinical oncology 26 (3) (2020)
Tadahiro Shoji, Hisashi Eto, Takanori Sato, Rikako Soma, Daisuke Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Takayuki Nagasawa, Seiya Sato, Masahiro Kagabu, Tsukasa Baba
A New Therapeutic Strategy for Recurrent Ovarian Cancer-Bevacizumab beyond Progressive Disease. Healthcare (Basel, Switzerland) 7 (3) (2019)

Masahiro Kagabu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masahiro Kagabu